Rapid induction of uterine tumors with p53 point mutations in heterozygous p53-deficient CBA mice given a single intraperitoneal administration of N-ethyl-N-nitrosourea

Carcinogenesis

Volumn 21, Issue 5, 2000, Pages 1039-1042

  Mitsumori, Kunitoshi ^a   Onodera, Hiroshi ^a   Shimo, Takeo ^a   Yasuhara, Kazuo ^a   Takagi, Hisayoshi ^a   Koujitani, Takatoshi ^a   Hirose, Masao ^a   Maruyama, Chika ^b   Wakana, Shigeharu ^b  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLNITROSOUREA; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; LUNG ADENOMA; LYMPHOMA; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SARCOMA; TUMOR SUPPRESSOR GENE; UTERUS CANCER;

EID: 0034103236     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.5.1039     Document Type: Article

References (32)

1. Fujimoto, K., Yamada, Y., Okajima, E., Kakizoe, T., Sasaki, H., Sugimura, T. and Terada, M. (1992) Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res., 52, 1393-1398.
2. Daridoff, A.M., Kerns, B.J.M., Iglehart, J.D. and Marks, J.R. (1991) Maintenance of p53 alterations throughout breast cancer progression. Cancer Res., 51, 2605-2610.
3. Sommer, S., Cunningham, J., McGovern, R.M., Saitoh, S., Schroeded, J. J., Wold, L.E. and Kovach, J.S. (1991) Pattern of p53 gene mutations in breast cancers of women of the Midwestern United States. J. Natl Cancer Inst., 84, 246-252.
4. Hollstein, M.C., Metcalf, R.A., Welsh, J.A., Montesano, R. and Harris, C.C. (1990) Frequent mutation of the p53 gene in human esophageal cancer. Proc. Natl Acad. Sci. USA, 87, 9958-9961.
5. Tamura, G., Kihana, T., Nomura, K., Terada, M., Sugimura, T. and Hirohashi, S. (1991) Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res., 52, 3056-3058.
6. Takahashi, T., Nau, M.M., Chiba, I., Birrer, M.J., Rosenberg, R.K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A.F. and Minna, J.D. (1989) p53: frequent target for genetic abnormalities in lung cancer. Science, 246, 491-494.
7. Tsuda, H., Jiko, K., Tsugane, S., Yajima, M., Yamada, T., Tanemura, K., Tsunematsu, R., Ohmi, K., Sonoda, T. and Hirohashi, S. (1995) Prognostic value of p53 protein accumulation in cancer cell nuclei in adenocarcinoma of the uterine cervix. Jpn J. Cancer Res., 86, 1049-1053.
8. Watanabe, M., Ushijima, T., Kakiuchi, H., Shiraishi, T., Yatani, R., Shimazaki, J., Kotake, T., Sugimura, T. and Nagao, M. (1994) p53 gene mutations in human prostate cancers in Japan: different mutation spectra between Japan and western countries. Jpn J. Cancer Res., 85, 904-910.
9. Hartwell, L.H. and Kastan, M.B. (1994) Cell cycle control and cancer. Science, 266, 1821-1828.
10. Marx, J. (1993) How p53 suppresses cell growth. Science, 262, 1644-1645.
11. Yin, Y., Tainsky, M.A., Bischoff, F.Z., Strong, L.C. and Wahl, G.M. (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70, 937-948.
12. Cross, S.M., Sanchez, C.A., Morgan, C.A., Schmike, M.K., Ramel, S., Idzerda, R.L., Raskind, W.H. and Reed, B.J. (1995) A p53-dependent mouse spindle checkpoint. Science, 267, 1353-1356.
13. Nigro, J.M., Baker, S.J., Preisinger, A.C., Jessup, J.M., Hostetter, R.H., Cleary, K., Binger, S.H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F.S., Weston, A., Modai, R., Harris, C.C. and Vogelstein, B. (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature, 342, 705-708.
14. Fukasawa, K., Wiener, F., Woude, G.F.V. and Mai, S. (1997) Genomic instability and apoptosis are frequent in p53 deficient young mice. Oncogene, 15, 1295-1302.
15. Donehower, L.A., Harvey, M., Slagle, B., McArthur, M.J., Montogomery, C.A. Jr, Butel, J.S. and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
16. Tennant, R.W., French, J.E. and Spalding, J.W. (1995) Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ. Health Perspect., 103, 942-950.
17. Tennant, R.W., Spalding, J. and French, J.E. (1996) Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens. Mutat. Res., 356, 119-127.
18. Dunnick, J.K., Hardisty, J.F., Herbert, R.A., Seely, J.C., FurediMachacek, E.M., Foley, J.E., Lacks, G.D., Stasiewicz, S. and French, J.E. (1997) Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient (+/-) mice. Toxicol. Pathol., 25, 533-540.
19. Ozaki, K., Sukata, T., Yamamoto, S., Uwagawa, S., Seki, T., Kawasaki, H., Yoshitake, A., Wanibuchi, H., Koide, A., Mori, Y. and Fukushima, S. (1998) High susceptibility of p53 (+/-) knockout mice in N-butyl-N-(4-hydroxybuytl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in the residual allele. Cancer Res., 58 (suppl. 1), 3808-3811.
20. Magee, P.N. and Barnes, J.M. (1967) Carcinogenic nitroso compounds. Adv. Cancer Res., 10, 164-246.
21. Tsukada, T., Tomooka, Y., Takai, S., Ueda, Y., Nishikawa, S., Yagi, T., Tokunaga, T., Takeda, N., Suda, Y., Abe, S., Matsuo, I., Ikawa, Y. and Aizawa, S. (1993) Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene, 8, 3313-3322.
22. Vesselinovitch, S.D., Rao, K.V.N., Mihailovich, N., Rice, J.M. and Lombard, L.S. (1974) Development of a broad spectrum of tumors by ethylnitrosourea in mice and the modifying role of age, sex and strain. Cancer Res., 34, 2530-2538.
23. Poulsen, H.E. and Tayler, C.W. (1975) Histological typing of female genital tract tumors. In International Histological Classification of Tumours, no. 13. WHO, Geneva, pp. 63-66.
24. 1 hybrid mice. Carcinogenesis, 16, 2659-2666.
25. Trukhanova, L.S., Hong, H.H.L., Sills, R.C., Bowser, A.D., Gual, B., Boorman, G.A., Trusov, V.S., Devereux, T.R. and Dixon, D. (1998) Predominant p53 G to A transition mutation and enhanced cell proliferation in uterine sarcomas of CBA mice treated with 1,2-dimethylhydrazine. Toxicol. Pathol., 26, 367-374.
26. Maekawa, A., Takahashi, M., Ando, J. and Yoshida, M. (1999) Uterine carcinogenesis by chemicals/hormones in rodents. J. Toxicol. Pathol., 12, 1-11.
27. Niwa, K., Tanaka, T., Mori, H., Yokoyama. Y., Furui, T., Mori, H. and Tamaya, T. (1991) Rapid induction of endometrial carcinoma in ICR mice treated with N-methyl-N-nitrosourea and 17beta-estradiol. Jpn J. Cancer Res., 82, 1391-1396.
28. Oda, H., Zhang, S., Tsurutani, N., Shimizu, S., Nakatsuru, Y., Aizawa, S. and Ishikawa, T. (1997) Loss of p53 is an early event in induction of brain tumors in mice by transplacental carcinogen exposure. Cancer Res., 57, 646-650.
29. Burns, P.A., Gordon, A.J.E., Kunzman, K. and Glickman, B. (1988) Influence of neighbouring base sequence on the distribution and repair of ENU-induced lesions in Escherichia coli. Cancer Res., 48, 4455-4458.
30. Richardson, K.K., Richardson, F.C., Crosby, R.M. Swenberg, J.A. and Skopek, T.R. (1987) DNA base changes and alkylation following in vivo exposure of Escherichia coli to N-methyl-N-nitrosourea or N-ethyl-N-nitrosourea. Proc. Natl Acad. Sci. USA, 84, 344-348.
31. Meden, H., Neyer, R.D., Schauer, A. and Kuhn, W. (1991) Endometrial stromal sarcomas of the uterus. Anticancer Drugs, 2, 35-37.
32. Knippschild, U., Oren, M. and Deppert, W. (1996) Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion. Oncogene, 12, 1755-1765.